ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
162 hedge funds and large institutions have $305M invested in Antares Pharma, Inc. in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 56 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
5% less funds holding
Funds holding: 170 → 162 (-8)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
Holders
162
Holding in Top 10
3
Calls
$482K
Puts
$141K
Top Buyers
| 1 | +$7.26M | |
| 2 | +$3.68M | |
| 3 | +$3.15M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.86M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$2.83M |
Top Sellers
| 1 | -$3.24M | |
| 2 | -$2.56M | |
| 3 | -$2.24M | |
| 4 |
Two Sigma Advisers
New York
|
-$1.8M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.63M |